Dr. King is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
430 W Sunset Rd
Suite #135
San Antonio, TX 78209Phone+1 210-455-1002Fax+1 210-455-1003
Education & Training
Naval Hospital (Pensacola)Residency, Family Medicine, 2001 - 2004
Texas A&M; Health Science Center College of MedicineClass of 2001
Certifications & Licensure
TX State Medical License 2005 - 2025
LA State Medical License 2003 - 2006
American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2012-2013
Publications & Presentations
PubMed
- Effect of glucagon-like peptide-1 receptor agonists on vascular risk factors among adults with type 2 diabetes and established atherosclerotic cardiovascular disease.Aaron King, Xi Tan, Neil Dhopeshwarkar, Rhonda Bohn, Katherine Dea
American Journal of Preventive Cardiology. 2025-03-01 - Recent trends in GLP-1 RA and SGLT2i use among people with type 2 diabetes and atherosclerotic cardiovascular disease in the USA.Aaron King, Xi Tan, Neil Dhopeshwarkar, Rhonda Bohn, Katherine Dea
BMJ Open Diabetes Research & Care. 2024-10-04 - 1 citationsDurability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP-4i) in US Adults with Type 2 Diabetes.Xi Tan, Yuanjie Liang, Cory Gamble, Aaron King
Diabetes Therapy. 2024-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
